Emergent BioSolutions Inc.
NYSE · Healthcare · Pharmaceutical Preparations · Gaithersburg, MD
EBS chart
What traders are saying about $EBS
Latest postsEmergent BioSolutions Inc. news
- Emergent BioSolutions Inc. (EBS) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Emergent BioSolutions to Participate in Jefferies Global Healthcare Conference
Yahoo Finance ·
- Weekly Recap: Revenue guidance cut and $75 million of notes repurchased
TradingView ·
- Emergent BioSolutions Inc. (ER4.F) Seasonal returns chart - Yahoo Finance
Yahoo Finance Singapore ·
- Erste Group Bank (EBS) Stock Price, Chart & Analysis
www.debelegger.nl ·
- Emergent Biosolutions Stock Price Forecast. Should You Buy EBS?
StockInvest.us ·
- Emergent BioSolutions cuts FY26 guidance amid U...
Pluang ·
- Emergent BioSolutions: A Turnaround Still Waiting For Consistent Execution (NYSE:EBS)
Seeking Alpha ·
- Emergent BioSolutions Inc. (ER4.F) Analyst Insights, Price Targets & Recommendations - Yahoo Finance
Yahoo! Finance Canada ·
- How Emergent Biosolutions Inc. (EBS) Affects Rotational Strategy Timing
Stock Traders Daily ·
- Emergent BioSolutions Inc (EBS) (Q3 2026) Earnings Call Highlights: Revenue Timing Weighs on ...
Yahoo Finance ·
- Emergent Biosolutions Inc. R (ER4.MU) Seasonal returns chart
Yahoo Finance UK ·
Emergent BioSolutions Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $742.9M | $1.04B | $1.05B | – |
| Net income | $52.6M | -$190.6M | -$760.5M | -$211.6M |
| Diluted EPS | $0.93 | $-3.60 | $-14.85 | $-4.22 |
| Total assets (year end) | $1.32B | $1.39B | $1.82B | $3.17B |
| Cash and equivalents (year end) | $205.4M | $99.5M | $111.7M | $642.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
- 8-K8-K PR 11.4.2026
- 10-Q10-Q 9.30.26
- 8-K8-K ER 11.2.26
- 8-K8-K CFO 10.16.2026
- 8-K8-K
- 8-K8-K
- 10-Q10-Q
- 8-K8-K
- 8-K8-K
- 10-Q10-Q
- 8-K8-K
- 8-K8-K
About Emergent BioSolutions Inc.
- Ticker
- EBS (NYSE)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Gaithersburg, MD
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1367644
Frequently asked questions
What exchange is Emergent BioSolutions Inc. listed on?
Emergent BioSolutions Inc. trades on the NYSE under the ticker symbol EBS.
What industry is Emergent BioSolutions Inc. in?
Emergent BioSolutions Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Emergent BioSolutions Inc. headquartered?
Emergent BioSolutions Inc.'s business address on file with the SEC is in Gaithersburg, MD.
When does Emergent BioSolutions Inc.'s fiscal year end?
Emergent BioSolutions Inc.'s fiscal year ends on December 31.
How much revenue did Emergent BioSolutions Inc. report?
Emergent BioSolutions Inc. reported $742.9M in revenue for calendar year 2025, according to its SEC filings.